Directive 2019/1833 - Amendment of Annexes I, III, V and VI to Directive 2000/54/EC as regards purely technical adjustments

Please note

This page contains a limited version of this dossier in the EU Monitor.

1.

Current status

This directive has been published on October 31, 2019, entered into force on November 20, 2019 and should have been implemented in national regulation on November 24, 2020 at the latest.

2.

Key information

official title

Commission Directive (EU) 2019/1833 of 24 October 2019 amending Annexes I, III, V and VI to Directive 2000/54/EC of the European Parliament and of the Council as regards purely technical adjustments
 
Legal instrument Directive
Number legal act Directive 2019/1833
CELEX number i 32019L1833

3.

Key dates

Document 24-10-2019; Date of adoption
Publication in Official Journal 31-10-2019; OJ L 279 p. 54-79
Effect 20-11-2019; Entry into force Date pub. +20 See Art 3
End of validity 31-12-9999
Transposition 24-11-2020; See Art 2.1 And 32020L0739
20-11-2021; See Art 2.1

4.

Legislative text

31.10.2019   

EN

Official Journal of the European Union

L 279/54

 

COMMISSION DIRECTIVE (EU) 2019/1833

of 24 October 2019

amending Annexes I, III, V and VI to Directive 2000/54/EC of the European Parliament and of the Council as regards purely technical adjustments

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (1), and in particular Article 19 thereof,

Whereas:

 

(1)

Principle 10 of the European Pillar of Social Rights (2), proclaimed at Gothenburg on 17 November 2017, provides that every worker has the right to a healthy, safe and well-adapted working environment. The workers’ right to a high level of protection of their health and safety at work and to a working environment that is adapted to their professional needs and that enables them to prolong their participation in the labour market includes protection from exposure to biological agents at work.

 

(2)

The implementation of the directives related to the health and safety of workers at work, including Directive 2000/54/EC, was the subject of an ex-post evaluation, referred to as a REFIT evaluation. The evaluation looked at the directives’ relevance, at research and at new scientific knowledge in the various fields concerned. The REFIT evaluation, referred to in the Commission Staff Working Document (3), concludes, among other things, that the classified list of biological agents in Annex III to Directive 2000/54/EC needs to be amended in light of scientific and technical progress and that consistency with other relevant directives should be enhanced.

 

(3)

In its Communication ‘Safer and Healthier Work for All — Modernisation of the EU Occupational Safety and Health Legislation and Policy’ (4), the Commission reiterated that while the REFIT evaluation of the Union’s acquis on occupational health and safety confirmed that the legislation in this field is generally effective and fit-for-purpose, there is scope for updating outdated rules and ensuring better and broader protection, compliance and enforcement on the ground. The Commission emphasises the particular need to update the list of biological agents in Annex III to Directive 2000/54/EC.

 

(4)

Directive 2000/54/EC lays down rules to protect workers against risks to their health and safety, including the prevention of such risks, arising or likely to arise from exposure to biological agents at work. Directive 2000/54/EC applies to activities in which workers are exposed, or are potentially exposed, to biological agents as a result of their work, and states the measures to be taken in the case of any activity likely to involve a risk of exposure to biological agents, to determine the nature, degree and duration of workers’ exposure to biological agents.

 

(5)

Since the results of a risk assessment can show an unintended exposure to biological agents, there could be other work activities not included in Annex I to Directive 2000/54/EC that should also be taken into consideration. Therefore, the indicative list of activities set out in Annex I to Directive 2000/54/EC should be amended to include an introductory phrase in order to clarify the non-exhaustive nature of the list.

 

(6)

Annex III to Directive 2000/54/EC sets out the list of biological agents known to infect humans, classified according to their level of risk of infection. In line with introductory note 6 in that Annex, the list should be amended to take into account the latest state of knowledge as regards scientific development that have brought about significant changes since the list was last updated, particularly as regards the taxonomy,...


More

This text has been adopted from EUR-Lex.

 

5.

Sources and disclaimer

For further information you may want to consult the following sources that have been used to compile this dossier:

This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.

 

6.

Full version

This page is also available in a full version containing the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and the related cases of the European Court of Justice.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

7.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.